Laurion Capital Management LP Praxis Precision Medicines, Inc. Transaction History

Laurion Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.88 - $2.49 $2,686 - $3,558	-1,429 Reduced 0.72%	196,669 $468,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $4.77 $721,427 - $1.38 Million	-288,571 Reduced 59.3%	198,098 $450,000
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $102,742 - $665,771	-58,710 Reduced 10.76%	486,669 $1.19 Million
Q1 2022 May 16, 2022	SELL	$10.21 - $20.29 $73,512 - $146,088	-7,200 Reduced 1.3%	545,379 $5.57 Million
Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $972,080 - $1.33 Million	58,000 Added 11.73%	552,579 $10.9 Million

Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $12,111 - $20,777	921 Added 0.19%	494,579 $9.15 Million
Q2 2021 Aug 13, 2021	BUY	$18.28 - $33.05 $8.11 Million - $14.7 Million	443,658 Added 887.32%	493,658 $9.02 Million
Q4 2020 Feb 12, 2021	BUY	$27.25 - $55.82 $1.36 Million - $2.79 Million	50,000 New	50,000 $2.75 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $1.84B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.